Galzin ® (zinc acetate capsules) is now available for maintenance treatment of patients with Wilson disease who have been initially treated with a chelating agent, according to Eton Pharmaceuticals.

Galzin is FDA-approved for the maintenance treatment of patients with Wilson disease who have been initially treated with a chelating agent. It is the only FDA-approved zinc therapy for Wilson ...

Eton Pharmaceuticals (ETON) announced that it has launched Galzin capsules. Galzin is FDA-approved for the maintenance treatment of patients with Wilson disease who have been initially treated ...

Eton Pharmaceuticals has launched Galzin® (zinc acetate) capsules, the only FDA-approved zinc therapy for Wilson disease patients who have previously been treated with a chelating agent.

As part of this expanded collaboration, Optime Care will serve as the specialty pharmacy provider of a third product for Eton, dispensing the newly acquired GALZIN ® (zinc acetate), an FDA ...

Galzin is FDA-approved for the maintenance treatment of patients with Wilson disease who have been initially treated with a chelating agent. It is the only FDA-approved zinc therapy for Wilson disease ...

As part of this expanded collaboration, Optime Care will serve as the specialty pharmacy provider of a third product for Eton, dispensing the newly acquired GALZIN ® (zinc acetate), an FDA-approved ...